Norges Bank’s Insys Therapeutics, Inc. INSY Stock Holding History

Norges Bank’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-627,077	Closed	-$2.19M	–	2141
2018 Q4	$2.19M	Hold	627,077	–	–	﹤0.01%	1998
2018 Q3	$6.32M	Buy	627,077 +219,780	+54%	+$1.75M	﹤0.01%	1931
2018 Q2	$2.95M	Sell	407,297 -491,614	-55%	-$3.43M	﹤0.01%	2002
2018 Q1	$5.43M	Sell	898,911 -86,801	-9%	-$717K	﹤0.01%	1883
2017 Q4	$9.48M	Hold	985,712	–	–	﹤0.01%	1757
2017 Q3	$8.75M	Hold	985,712	–	–	﹤0.01%	1771
2017 Q2	$12.5M	Hold	985,712	–	–	﹤0.01%	1659
2017 Q1	$10.4M	Buy	985,712 +615,313	+166%	+$6.56M	﹤0.01%	1731
2016 Q4	$3.41M	Buy	370,399 +56,665	+18%	+$640K	﹤0.01%	1919
2016 Q3	$3.53M	Buy	313,734 +49,200	+19%	+$748K	﹤0.01%	1920
2016 Q2	$3.42M	Hold	264,534	–	–	﹤0.01%	1935
2016 Q1	$4.23M	Buy	264,534 +50,000	+23%	+$950K	﹤0.01%	1888
2015 Q4	$6.14M	Buy	214,534 +90,536	+73%	+$2.51M	﹤0.01%	1813
2015 Q3	$3.53M	Buy	+123,998	New	+$4.56M	﹤0.01%	1941

Other funds holding INSY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Norges Bank's INSY Position: Q1 2019 in Review

Norges Bank sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 627,077 shares — an estimated $2.19M sold.

Norges Bank first reported a position in INSY in Q3 2015 and held it in 14 quarters. The position peaked at $12.5M in Q2 2017. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

Norges Bank reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
Norges Bank sold 627,077 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $2.19M.
Norges Bank first reported a position in Insys Therapeutics, Inc. in Q3 2015 and held it in 14 quarters.
Norges Bank's Insys Therapeutics, Inc. position peaked at $12.5M in Q2 2017.
98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on Norges Bank's 13F filing for Q1 2019, filed 9 May 2019.